Where does Aptamir Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Aptamir Therapeutics, Inc. ranks #38,839 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Aptamir Therapeutics, Inc. hold?

Aptamir Therapeutics, Inc. holds 6 US utility patents granted between 2015 and 2025, spanning 4 technology areas.

What is Aptamir Therapeutics, Inc.'s Innovation Score?

Aptamir Therapeutics, Inc. has an Innovation Score of 30.4 out of 100 (34th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Aptamir Therapeutics, Inc.'s patent grant rate increasing or decreasing?

Aptamir Therapeutics, Inc.'s recent grant velocity is -75% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Aptamir Therapeutics, Inc.'s patents?

Aptamir Therapeutics, Inc.'s patents average 16.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Aptamir Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Aptamir Therapeutics, Inc.

Q: What technology areas does Aptamir Therapeutics, Inc. focus on?

Aptamir Therapeutics, Inc.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 6 patents, ranking #1,557 of 4,144 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

USPTO PatentsView assignee record - 6 granted patents across 4 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Aptamir ranks #38,839 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 4 technology areas.

#38,839
of 49,997 US assignees by volume: 34th percentile
by Innovation Score (30.4/100): 16.5
avg claims per patent: -75%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R38839 · US Corporation #38,839 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 6 grants
LOWER-Q #38,839/49,997
PHOTO-FINISH Applied Lacquer…
CPC-NARROW C12N · 4 areas
INNOV-THIN 30.4/100
CLAIMS-RICH 16.5 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -75% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Applied Lacquer Industries Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Aptamir’s 30.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.7 pts (22%) Velocity 6.7 pts (22%) Breadth 7.1 pts (23%) Claim depth 9.9 pts (33%)

Qualcomm Incorporated · highest

85
Aptamir Therapeutics · this assignee

30
3D Lighting… · lowest

7

What this shows Aptamir's Innovation Score is 30.4/100 (34th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Aptamir?

Each dot is one of Aptamir’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Aptamir’s own 16.5 claims/patent is ABOVE the 15.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Aptamir vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Aptamir's grants concentrate

Aptamir Therapeutics, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). By volume, Aptamir sits between Applied Lacquer Industries Inc. and Aquaoptics Corp..

Aptamir's three-year grant acceleration

Aptamir Therapeutics, Inc. shows 1 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Applied Lacquer I…

6
Applikate

6
Aprinoia Therapeu…

6
APT Advanced Poly…

6
Apterna

6
Aptose Biosciences

6
Aqua Storage Reta…

6
Aquaoptics

6
Aptamir Therapeut… ◀

6

What this shows Aptamir holds 6 patents at rank #38,667, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Aptamir

By rank, the assignees closest to #38,667 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Aptamir's primary technology class.

Aptamir's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 34th percentile higher than 34% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Aptamir Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	16.7%
2016	1	16.7%
2017	1	16.7%
2019	1	16.7%
2023	1	16.7%
2025partial year	1	16.7%

Which technologies does Aptamir Therapeutics, Inc. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 6

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 4

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 2

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 1

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Aptamir Therapeutics, Inc.'s patent record in context - here's where to go next.

Aptamir Therapeutics, Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 100% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #38,839 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Aptamir Therapeutics, Inc. against Applied Lacquer Industries Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 30.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.